[Corrigendum] Rab22a is a novel prognostic marker for cell progression in breast cancer

• Authors:
  • Miao He
  • Leihua Shen
  • Chengwei Jiang
  • Ge Gao
  • Keren Wang
  • Yan Jiao
  • Liang Sun
  • Yingnan Cui
  • Zirui Ke
  • Zhaoying Yang

• View Affiliations

  
  Affiliations: Department of Anesthesia, The Second Hospital of Jilin University, Changchun, Jilin 130022, P.R. China, Department of General Surgery, Xi'an Central Hospital, Xi'an, Shanxi 710000, P.R. China, Department of Pathology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Breast Surgery, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
• Published online on: January 11, 2021     https://doi.org/10.3892/ijmm.2021.4851
• Article Number: 18

• Copyright : © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article